Lifeboat Foundation

A group of scientists from the Russian Academy of Sciences (ICG SB RAS) and the TSU Biological Institute has established a path through which nanoparticles of viruses and organic and inorganic substances from the environment enter the brain. Additionally, the researchers report a simple and inexpensive way to block their entry. The data obtained by the project could play a large role in medicine and pharmaceuticals, where nanoparticles are increasingly used for the diagnosis and treatment of serious diseases.

“There are a large number of nanoparticles of a wide variety of chemical elements and their compounds in the environment, ranging from harmless to toxic, for example, heavy metal oxides,” says Mikhail Moshkin, director of the Center for Laboratory Animal Genetic Resources of the ICG SB RAS. “Scientists have accumulated data that indicate the adverse effect of nanoparticles, for example, people who live closer than 50 meters to large highways may develop neurodegenerative diseases (Alzheimer’s, Parkinson’s and others) due to the accumulation of nanosized particles in the brain.”

The researchers sought to determine how nanoparticles enter the brain. They cannot penetrate through the lungs and blood vessels because the blood-brain barrier blocks them from the brain. Experiments conducted on rodents helped calculate the trajectory of the movement of nanoparticles.

Epigenetic reprogramming. “We are very radical life extensionists, neither healthspan increase no morbidity compression are enough, we would like to add decades if not centuries to the human lifespan.”

Yuri Deigin Founder of Youthereum, speaking at Master Investor’s Investing in the Age of Longevity 2019 event.

Continue reading “Yuri Deigin | Youthereum | Investing in the Age of Longevity 2019” »

A Chinese scientist who helped create the world’s first gene-edited babies has been sentenced to three years in prison.

He Jiankui shocked the world in 2018 when he announced that twin girls Lulu and Nana had been born with modified DNA to make them resistant to HIV, which he had managed using the gene-editing tool CRISPR-Cas9 before birth.

He, an associate professor at the Southern University of Science and Technology in Shenzhen, said at the time that he was “proud” of the achievement. He later claimed that a second woman was pregnant as a result of his research.

Glioblastoma is one of the most common and aggressive forms of brain cancer, and it is particularly difficult to treat. Now, researchers from the University of Pennsylvania School of Medicine have come up with a new approach to treatment for the disease, by growing organoids based on a patient’s own tumor to find the most effective treatments. Digital Trends spoke to senior author Dr. Donald O’Rourke to learn more.

The technique uses mini-brains — pea-sized organoids grown from stem cells which recreate features of full-scale brains. The mini-brains are similar enough to real brains that they can be used for testing out medical treatments to see how a full-sized brain would respond.

The breakthrough in this research is regarding treatment individualization. One of the challenges of treating a complex disease like brain cancer is that different people respond in different ways to the various treatment options available. After surgery has been performed to remove a tumor, doctors typically begin further treatment using radiation or chemotherapy around one month later. That means there isn’t always time to use perform genetic analysis to see which treatment might be best suited for a particular patient — the doctors need to know what will work and start further treatment as soon as possible.

We might one day combine tardigrade DNA into our own cells.

Talk with an Alzheimer’s researcher and you’ll likely hear the same lament: Finding a treatment or cure is incredibly challenging because scientists are not even certain what exactly causes the neurological disease in the first place.

In fact, researchers speak of a “web of causation” that can lead to Alzheimer’s. In addition to genetics, scientists look to so-called lifestyle elements such as blood pressure and blood sugar levels. Even the bacteria that live in our mouths are being scrutinized for their potential role in Alzheimer’s.

One element that researchers are completely certain about is that people who carry the apolipoprotein E4 gene — known as APOE4 — are at a greater risk of developing Alzheimer’s.

Sickle Cell Therapy With CRISPR Gene Editing Shows Promise : Shots — Health News NPR tells the exclusive, behind-the-scenes story of the first person with a genetic disorder to be treated in the United States with the revolutionary gene-editing technique CRISPR.

With new technology to edit genes, scientists are now working on things that once seemed impossible. But what are the boundaries? See the full 60 Minutes interview with Church, here: https://cbsn.ws/34ZhuTs

Watch Full Episodes of “60 Minutes” HERE: http://cbsn.ws/1Qkjo1F
Get more “60 Minutes” from “60 Minutes: Overtime” HERE: http://cbsn.ws/1KG3sdr
Relive past episodies and interviews with “60 Rewind” HERE: http://cbsn.ws/1PlZiGI
Follow “60 Minutes” on Instagram HERE: http://bit.ly/23Xv8Ry
Like “60 Minutes” on Facebook HERE: http://on.fb.me/1Xb1Dao
Follow “60 Minutes” on Twitter HERE: http://bit.ly/1KxUsqX
Follow “60 Minutes” on Google+ HERE: http://bit.ly/1KxUvmG

Continue reading “The complicated ethics of genetic engineering” »

Neurochemicals such as serotonin and dopamine play crucial roles in cognitive and emotional functions of our brain. Vesicular monoamine transporter 1 (VMAT1) is one of the genes responsible for transporting neurotransmitters and regulating neuronal signaling. A research team led by Tohoku University has reconstructed ancestral VMAT1 proteins, revealing the functional changes in neurotransmitter uptake of VMAT1 throughout the course of human evolution.

Human bodies are made up of millions of cells. Each individual contains a specific set of instruction of codes that make up all of a living thing’s genetic material. These instructions are known as genomes. PhD candidate Daiki Sato and Professor Masakado Kawata of the Graduate School of Life Sciences at Tohoku University, and two of the authors involved in the current study, previously discovered VMAT1 to be one of the genes that had evolved throughout human lineage.

VMAT 1 contains two human-specific mutations, or where the genomes changed, with the change being represented as 130Glu to 130Gly and from 136Asn to 136Thr. Previous studies have shown that having the new 130Gly/136Thr variant decreases the uptake of neurotransmitters and is associated with higher depression and/or anxiety. In this study, Sato, Kawata and their colleagues revealed the evolutionary changes in neurotransmitter uptake of VMAT1 by reconstructing ancestral VMAT1 proteins. First they applied a fluorescent substrate to visualize and quantify the neurotransmitter uptake of each genotype. The ancestral (130Glu/136Asn) VMAT1 protein exhibited an increased uptake of neurotransmitters compared to a derived (130Gly/136Thr) genotype. Given that the derived (130Gly/136Thr) genotype is shown to be associated with depression and/or anxiety in modern human populations. “This results of our study reveal that our ancestors may have been able to withstand higher levels of anxiety or depression,” noted the authors.

Continue reading “Evolutionary Changes in Brain Potentially Make us More Prone to Anxiety” »